Fragile X syndrome Archives - European Biotechnology Magazine

Tag Archive for: Fragile X syndrome

The Fragile X mutation is a type of genetic mutation called a repeat expansion. This repeat expansion occurs on the FMR1 gene, on the long arm of the X chromosome leading to gene silencing if more than 200 repeats occur.

Servier acquires Kaerus Bioscience’s FXS candidate for US$450m

In a US$450m deal with UK-based Kaerus Bioscience Ltd, Servier SA has acquired the development and commercialisation rights to KER-0193, a Phase II-ready drug candidate for the treatment of rare Fragile X syndrome, the most common monogenic cause of autism.